Barrett's esophagus in 2012: Updates in pathogenesis, treatment, and surveillance

被引：6
作者：
Chandra S. [1 ]
Gorospe E.C. [1 ]
Leggett C.L. [1 ]
Wang K.K. [1 ]
机构：
[1] Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905
来源：
Current Gastroenterology Reports | 2013年 / 15卷 / 5期
关键词：
Acid reflux; Barrett's esophagus; Biomarkers; Confocal laser endomicroscopy; Cryotherapy; Endoscopic mucosal resection; Esophageal adenocarcinoma; Narrow band imaging; Obesity; Optical coherence tomography; Photodynamic therapy; Radiofrequency ablation;
D O I：
10.1007/s11894-013-0322-8
中图分类号：
学科分类号：
摘要：
Barrett's esophagus (BE) is the only established precursor lesion in the development of esophageal adenocarcinoma (EAC) and it increases the risk of cancer by 11-fold. It is regarded as a complication of gastroesophageal reflux disease. There is an ever-increasing body of knowledge on the pathogenesis, diagnosis, treatment, and surveillance of BE and its associated dysplasia. In this review, we summarize the latest advances in BE research and clinical practice in the past 2 years. It is critical to understand the molecular underpinnings of this disorder to comprehend the clinical outcomes of the disease. For clinical gastroenterologists, there is also continuous growth of endoscopic approaches which is daunting, and further improvements in the detection and treatment of BE and early EAC are anticipated. In the future, we may see the increased role of biomarkers, both molecular and imaging, in both diagnostic and therapeutic strategies for BE. © 2013 Springer Science+Business Media New York.
引用
收藏
相关论文
共 58 条
  • [21] Paz-Filho G., Lim E.L., Wong M.L., Licinio J., Associations between adipokines and obesity-related cancer, Front Biosci J Virtual Libr, 16, pp. 1634-1650, (2011)
  • [22] Howard J.M., Beddy P., Ennis D., Keogan M., Pidgeon G.P., Reynolds J.V., Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma, Br J Surg, 97, 7, pp. 1020-1027, (2010)
  • [23] Leggett C., Calvin A.D., Gorospe E.C., Et al., Obstructive sleep apnea is a risk factor for Barrett's esophagus, Gastroenterology, 142, 5, (2012)
  • [24] Cook M.B., Shaheen N.J., Anderson L.A., Et al., Cigarette smoking increases risk of Barrett's esophagus: An analysis of the Barrett's and esophageal adenocarcinoma consortium, Gastroenterology, 142, 4, pp. 744-753, (2012)
  • [25] Jacobson B.C., Giovannucci E.L., Fuchs C.S., Smoking and Barrett's esophagus in women who undergo upper endoscopy, Dig Dis Sci, 56, 6, pp. 1707-1717, (2011)
  • [26] Coleman H.G., Bhat S., Johnston B.T., McManus D., Gavin A.T., Murray L.J., Tobacco smoking increases the risk of high-grade dysplasia and cancer among patients with Barrett's esophagus, Gastroenterology, 142, 2, pp. 233-240, (2012)
  • [27] Shariff M.K., Bird-Lieberman E.L., O'donovan M., Et al., Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus, Gastrointest Endosc, 75, 5, pp. 954-961, (2012)
  • [28] Peery A.F., Hoppo T., Garman K.S., Et al., Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video), Gastrointest Endosc, 75, 5, pp. 945-953, (2012)
  • [29] Kadri S.R., Lao-Sirieix P., O'donovan M., Et al., Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: Cohort study, BMJ, 341, (2010)
  • [30] Benaglia T., Sharples L.D., Fitzgerald R.C., Lyratzopoulos G., Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for barrett's esophagus, Gastroenterology, (2012)
123456